![Piet Wigerinck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Piet Wigerinck
Direttore/Membro del Consiglio presso
IPSEN
Patrimonio netto: 124 266 $ in data 31/05/2026
Profilo
Attualmente, Piet Wigerinck è direttore scientifico di Galapagos NV. È anche nel consiglio di amministrazione di Ipsen SA e Ipsen Pharma SAS. In passato è stato vicepresidente di Drug Discovery & Early Development presso Tibotec Pharmaceuticals e vicepresidente di Drug Discovery & Development Solutions Ltd. Il Dr. Wigerinck ha ricevuto un dottorato dalla Katholieke Universiteit Leuven.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IPSEN SA 0% | 31/12/2025 | 680 ( 0% ) | 124 266 $ | 31/05/2026 |
Posizioni attive di Piet Wigerinck
| Società | Posizione | Inizio |
|---|---|---|
| IPSEN | Direttore/Membro del Consiglio | 01/05/2018 |
Antwerp University Hospital
 Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Direttore/Membro del Consiglio | - |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Direttore/Membro del Consiglio | - |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Direttore/Membro del Consiglio | - |
Symeres BV
 Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Piet Wigerinck
| Società | Posizione | Fine |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direttore Tecnico/Scientifico/R&S | 31/12/2021 |
UZA Foundation | Direttore/Membro del Consiglio | - |
Xinvento BV
 Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Fondatore | - |
Tibotec Virco Comm. VA
 Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Piet Wigerinck
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Antwerp University Hospital
Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Health Services |
Tibotec Virco Comm. VA
Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Commercial Services |
Drug Discovery & Development Solutions Ltd.
 Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Health Technology |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Health Technology |
UZA Foundation |
